Overview
Key stats
Fundamentals Sep 10- Open
- $991.68
- 52-wk high
- $1,072.75
- High
- $1,008.93
- 52-wk low
- $661.85
- Low
- $988.69
- Prev close
- $1,007.07
- Mkt cap
- $63.00B
- P/E
- 38.4x
- Volume
- 209.9K
- Fwd P/E
- 28.0x
- Beta
- -0.03
- P/S
- 11.8x
- P/B
- 7.7x
- Profit margin
- +32.3%
- Op margin
- +32.0%
- ROE
- +23.6%
What do analysts expect?
Analyst target and ratings are on paid plans
See the 12-month consensus target and the buy/hold/sell rating split.
Unlock the full resultsSmart money
8 funds hold a position.
What funds are doing
Activist stakes, short interest & more
Earnings
Earnings came in 16.7% above what analysts expected.
Earnings per share
$6.27 expected
Reports Oct 22, 2026, in 42 days
EPS expected
$6.38 to $8.89
Revenue expected
19 analysts
Last 30 days
Analysts raising estimates
Estimate drift
Change in 30 days
Financials
What it sold, what it cost, what was left.
| USD | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|
| What came in | ||||
| Revenue | $1.13B | $3.21B | $1.30B | $2.82B |
| Cost of what it sold | $109.4M | $339.9M | $121.0M | $279.3M |
| Gross profit | $1.02B | $2.87B | $1.18B | $2.54B |
| What it spent | ||||
| Research and development | $355.7M | $443.0M | $443.0M | $486.0M |
| Sales and admin | $336.3M | $422.5M | $355.0M | $532.5M |
| Other operating costs | $85.0M | $1.15B | $106.0M | $671.1M |
| Total operating expenses | $777.0M | $2.01B | $904.0M | $1.69B |
| What was left | ||||
| Operating profit | $350.0M | $850.8M | $394.0M | $846.8M |
| Interest on debt | $993.0K | $1.0M | $1.0M | $2.0M |
| Profit before tax | $386.1M | $991.7M | $426.0M | $958.9M |
| Tax | — | -$55.0M | — | $119.1M |
| Net profit | $344.3M | $1.05B | $366.0M | $838.8M |
| EBITDA | — | $1.01B | — | $863.8M |
Technicals
Price structure
This stock is trending upward.
Trend
Constructive
65 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace
News
What the news says
Coverage is bullish
Tone of tracked coverage
Argenx SE : Barclays reiterates its Buy rating
BullishSep 8argenx to Present at Upcoming Investor Conferences
NeutralSep 1
Macro
31 macro signals shaping ARGX right now
Unlock sector rotation, regime shifts, and macro event windows tied to this stock.
Unlock the full results